186 related articles for article (PubMed ID: 24465398)
1. Electroretinogram monitoring of dose-dependent toxicity after ophthalmic artery chemosurgery in retinoblastoma eyes: six year review.
Francis JH; Abramson DH; Gobin YP; Marr BP; Dunkel IJ; Riedel ER; Brodie SE
PLoS One; 2014; 9(1):e84247. PubMed ID: 24465398
[TBL] [Abstract][Full Text] [Related]
2. Efficacy and Toxicity of Intravitreous Chemotherapy for Retinoblastoma: Four-Year Experience.
Francis JH; Brodie SE; Marr B; Zabor EC; Mondesire-Crump I; Abramson DH
Ophthalmology; 2017 Apr; 124(4):488-495. PubMed ID: 28089679
[TBL] [Abstract][Full Text] [Related]
3. Simultaneous Bilateral Ophthalmic Artery Chemosurgery for Bilateral Retinoblastoma (Tandem Therapy).
Abramson DH; Marr BP; Francis JH; Dunkel IJ; Fabius AW; Brodie SE; Mondesire-Crump I; Gobin YP
PLoS One; 2016; 11(6):e0156806. PubMed ID: 27258771
[TBL] [Abstract][Full Text] [Related]
4. Carboplatin +/- topotecan ophthalmic artery chemosurgery for intraocular retinoblastoma.
Francis JH; Gobin YP; Dunkel IJ; Marr BP; Brodie SE; Jonna G; Abramson DH
PLoS One; 2013; 8(8):e72441. PubMed ID: 23991112
[TBL] [Abstract][Full Text] [Related]
5. Ophthalmic artery chemosurgery for less advanced intraocular retinoblastoma: five year review.
Abramson DH; Marr BP; Brodie SE; Dunkel I; Palioura S; Gobin YP
PLoS One; 2012; 7(4):e34120. PubMed ID: 22545080
[TBL] [Abstract][Full Text] [Related]
6. Association of electroretinography with visual outcomes after ophthalmic artery chemosurgery for retinoblastoma in ICRb D and E eyes.
Levin AM; Francis JH; McFadden M; Brodie S; Gobin YP; Abramson DH
PLoS One; 2019; 14(1):e0210647. PubMed ID: 30650131
[TBL] [Abstract][Full Text] [Related]
7. Ophthalmic artery chemosurgery for eyes with advanced retinoblastoma.
Abramson DH; Fabius AW; Francis JH; Marr BP; Dunkel IJ; Brodie SE; Escuder A; Gobin YP
Ophthalmic Genet; 2017; 38(1):16-21. PubMed ID: 28095092
[TBL] [Abstract][Full Text] [Related]
8. Superselective ophthalmic artery chemotherapy as primary treatment for retinoblastoma (chemosurgery).
Abramson DH; Dunkel IJ; Brodie SE; Marr B; Gobin YP
Ophthalmology; 2010 Aug; 117(8):1623-9. PubMed ID: 20381868
[TBL] [Abstract][Full Text] [Related]
9. Retinoblastoma Vitreous Seed Clouds (Class 3): A Comparison of Treatment with Ophthalmic Artery Chemosurgery with or without Intravitreous and Periocular Chemotherapy.
Francis JH; Iyer S; Gobin YP; Brodie SE; Abramson DH
Ophthalmology; 2017 Oct; 124(10):1548-1555. PubMed ID: 28545735
[TBL] [Abstract][Full Text] [Related]
10. Retinal reattachment and ERG recovery after ophthalmic artery chemosurgery for advanced retinoblastoma in eyes with minimal baseline retinal function.
Abdelhakim AH; Francis JH; Marr BP; Gobin YP; Abramson DH; Brodie SE
Br J Ophthalmol; 2017 May; 101(5):623-628. PubMed ID: 27539090
[TBL] [Abstract][Full Text] [Related]
11. Efficacy and toxicity of second-course ophthalmic artery chemosurgery for retinoblastoma.
Francis JH; Abramson DH; Gobin YP; Marr BP; Tendler I; Brodie SE; Dunkel IJ
Ophthalmology; 2015 May; 122(5):1016-22. PubMed ID: 25616769
[TBL] [Abstract][Full Text] [Related]
12. Total retinal detachments due to retinoblastoma: Outcomes following intra-arterial chemotherapy/ophthalmic artery chemosurgery.
Rowlands MA; Mondesire-Crump I; Levin A; Mauguen A; Francis JH; Dunkel IJ; Brodie SE; Gobin YP; Abramson DH
PLoS One; 2018; 13(4):e0195395. PubMed ID: 29698399
[TBL] [Abstract][Full Text] [Related]
13. Biochemical measures of ovarian function in female survivors of retinoblastoma treated with intra-arterial melphalan: an initial report.
Marathe PH; Dunkel IJ; Francis JH; Antal Z; Gobin YP; Abramson DH; Friedman DN
Ophthalmic Genet; 2022 Dec; 43(6):806-808. PubMed ID: 36695494
[TBL] [Abstract][Full Text] [Related]
14. Angiographic characteristics and treatment approach in patients undergoing intra-arterial chemotherapy for retinoblastoma.
Rusakevich AM; Nahhas MI; Zhou B; Dannenbaum MJ; Bretana ME; Schefler AC
Graefes Arch Clin Exp Ophthalmol; 2024 Apr; 262(4):1321-1328. PubMed ID: 38032379
[TBL] [Abstract][Full Text] [Related]
15. OCULAR PHARMACOLOGY OF CHEMOTHERAPY FOR RETINOBLASTOMA.
Schaiquevich P; Fabius AW; Francis JH; Chantada GL; Abramson DH
Retina; 2017 Jan; 37(1):1-10. PubMed ID: 27617542
[TBL] [Abstract][Full Text] [Related]
16. Persistence of retinal function after selective ophthalmic artery chemotherapy infusion for retinoblastoma.
Brodie SE; Pierre Gobin Y; Dunkel IJ; Kim JW; Abramson DH
Doc Ophthalmol; 2009 Aug; 119(1):13-22. PubMed ID: 19169884
[TBL] [Abstract][Full Text] [Related]
17. Local and systemic toxicity of intravitreal melphalan for vitreous seeding in retinoblastoma: a preclinical and clinical study.
Francis JH; Schaiquevich P; Buitrago E; Del Sole MJ; Zapata G; Croxatto JO; Marr BP; Brodie SE; Berra A; Chantada GL; Abramson DH
Ophthalmology; 2014 Sep; 121(9):1810-7. PubMed ID: 24819859
[TBL] [Abstract][Full Text] [Related]
18. Is intravitreal topotecan toxic to retinal function?
Nadelmann J; Francis JH; Brodie SE; Muca E; Abramson DH
Br J Ophthalmol; 2021 Jul; 105(7):1016-1018. PubMed ID: 32665221
[TBL] [Abstract][Full Text] [Related]
19. A phase I/II study of direct intraarterial (ophthalmic artery) chemotherapy with melphalan for intraocular retinoblastoma initial results.
Abramson DH; Dunkel IJ; Brodie SE; Kim JW; Gobin YP
Ophthalmology; 2008 Aug; 115(8):1398-404, 1404.e1. PubMed ID: 18342944
[TBL] [Abstract][Full Text] [Related]
20. Intra-Arterial Chemotherapy (Ophthalmic Artery Chemosurgery) for Group D Retinoblastoma.
Abramson DH; Daniels AB; Marr BP; Francis JH; Brodie SE; Dunkel IJ; Gobin YP
PLoS One; 2016; 11(1):e0146582. PubMed ID: 26756643
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
